113 related articles for article (PubMed ID: 22732675)
1. High frequency repetitive transcranial magnetic stimulation (rTMS) is effective in migraine prophylaxis: an open labeled study.
Misra UK; Kalita J; Bhoi SK
Neurol Res; 2012 Jul; 34(6):547-51. PubMed ID: 22732675
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache.
Kalita J; Laskar S; Bhoi SK; Misra UK
J Neurol; 2016 Nov; 263(11):2238-2246. PubMed ID: 27541044
[TBL] [Abstract][Full Text] [Related]
3. High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study.
Misra UK; Kalita J; Bhoi SK
J Neurol; 2013 Nov; 260(11):2793-801. PubMed ID: 23963471
[TBL] [Abstract][Full Text] [Related]
4. Low-frequency rTMS of the vertex in the prophylactic treatment of migraine.
Teepker M; Hötzel J; Timmesfeld N; Reis J; Mylius V; Haag A; Oertel WH; Rosenow F; Schepelmann K
Cephalalgia; 2010 Feb; 30(2):137-44. PubMed ID: 19515124
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Controlled Trial of High Rate rTMS Versus rTMS and Amitriptyline in Chronic Migraine.
Kalita J; Kumar S; Singh VK; Misra UK
Pain Physician; 2021 Sep; 24(6):E733-E741. PubMed ID: 34554691
[TBL] [Abstract][Full Text] [Related]
6. Is β endorphin related to migraine headache and its relief?
Misra UK; Kalita J; Tripathi GM; Bhoi SK
Cephalalgia; 2013 Apr; 33(5):316-22. PubMed ID: 23314782
[TBL] [Abstract][Full Text] [Related]
7. Role of β endorphin in pain relief following high rate repetitive transcranial magnetic stimulation in migraine.
Misra UK; Kalita J; Tripathi G; Bhoi SK
Brain Stimul; 2017; 10(3):618-623. PubMed ID: 28274721
[TBL] [Abstract][Full Text] [Related]
8. Increased migraine-free intervals with multifocal repetitive transcranial magnetic stimulation.
Leahu P; Bange M; Ciolac D; Scheiter S; Matei A; Gonzalez-Escamilla G; Chirumamilla VC; Groppa SA; Muthuraman M; Groppa S
Brain Stimul; 2021; 14(6):1544-1552. PubMed ID: 34673259
[TBL] [Abstract][Full Text] [Related]
9. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
Young W; Shaw J; Bloom M; Gebeline-Myers C
Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
[TBL] [Abstract][Full Text] [Related]
10. Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine.
Conforto AB; Amaro E; Gonçalves AL; Mercante JP; Guendler VZ; Ferreira JR; Kirschner CC; Peres MF
Cephalalgia; 2014 May; 34(6):464-72. PubMed ID: 24326236
[TBL] [Abstract][Full Text] [Related]
11. Effect of high rate rTMS on somatosensory evoked potential in migraine.
Kalita J; Bhoi SK; Misra UK
Cephalalgia; 2017 Nov; 37(13):1222-1230. PubMed ID: 27780897
[TBL] [Abstract][Full Text] [Related]
12. Induction of long-lasting changes of visual cortex excitability by five daily sessions of repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers and migraine patients.
Fumal A; Coppola G; Bohotin V; Gérardy PY; Seidel L; Donneau AF; Vandenheede M; Maertens de Noordhout A; Schoenen J
Cephalalgia; 2006 Feb; 26(2):143-9. PubMed ID: 16426268
[TBL] [Abstract][Full Text] [Related]
13. Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial.
Auvichayapat P; Janyacharoen T; Rotenberg A; Tiamkao S; Krisanaprakornkit T; Sinawat S; Punjaruk W; Thinkhamrop B; Auvichayapat N
J Med Assoc Thai; 2012 Aug; 95(8):1003-12. PubMed ID: 23061303
[TBL] [Abstract][Full Text] [Related]
14. Transcranial magnetic stimulation in migraine prophylaxis.
Leahu P; Matei A; Groppa S
J Med Life; 2018; 11(2):175-176. PubMed ID: 30140325
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study.
Mishra BR; Nizamie SH; Das B; Praharaj SK
Addiction; 2010 Jan; 105(1):49-55. PubMed ID: 20078462
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
17. High-frequency transcranial magnetic stimulation on motor cortex of patients affected by migraine with aura: a way to restore normal cortical excitability?
Brighina F; Palermo A; Daniele O; Aloisio A; Fierro B
Cephalalgia; 2010 Jan; 30(1):46-52. PubMed ID: 19438928
[TBL] [Abstract][Full Text] [Related]
18. Role of glutamate and its receptors in migraine with reference to amitriptyline and transcranial magnetic stimulation therapy.
Tripathi GM; Kalita J; Misra UK
Brain Res; 2018 Oct; 1696():31-37. PubMed ID: 29859974
[TBL] [Abstract][Full Text] [Related]
19. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial.
Wobrock T; Guse B; Cordes J; Wölwer W; Winterer G; Gaebel W; Langguth B; Landgrebe M; Eichhammer P; Frank E; Hajak G; Ohmann C; Verde PE; Rietschel M; Ahmed R; Honer WG; Malchow B; Schneider-Axmann T; Falkai P; Hasan A
Biol Psychiatry; 2015 Jun; 77(11):979-88. PubMed ID: 25582269
[TBL] [Abstract][Full Text] [Related]
20. A study of oxidative stress in migraine with special reference to prophylactic therapy.
Tripathi GM; Kalita J; Misra UK
Int J Neurosci; 2018 Apr; 128(4):318-324. PubMed ID: 28903615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
